HEALTH● LOW3h ago · Sep 22, 2026, 1:29 PM
Ionis gains on late-stage trial results for ulefnersen in ALS
Seeking Alpha Tech · global
Ionis Pharmaceuticals has seen gains following positive late-stage trial results for ulefnersen, a drug being developed for ALS. This indicates potential progress in treating the condition.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH26m agoU.S. to remove hundreds of thousands of Obamacare enrolleesSeeking Alpha TechHEALTH40m ago‘Robust mechanism in place to address any supply gap in essential medicines’The HinduHEALTH48m agoPasta sold at Walmart locations nationwide recalled over listeria concernsThe HillHEALTH53m agoSix years after pandemic, Allahabad HC quashes criminal proceedings against accused duo in Nizamuddin Markaz caseThe Hindu